Genetic variability of Plasmodium vivax from primary–relapses paired samples
© Araujo et al; licensee BioMed Central Ltd. 2012
Published: 9 November 2012
Human malaria is caused by protozoa from the genus Plasmodium. Approximately 40% of world population is at risk of infection. Plasmodium vivax is the most worldwide distributed human Plasmodium species. In Brazil, more than 300,000 cases of the disease were recorded in 2010 and 86% were caused by Plasmodium vivax. P. vivax infections are characterized by hepatic dormant forms, the hypnozoites and those are activated in varying intervals of time resulting in the typical relapses. Little is known about the mechanism of latency and activation of hypnozoites associated to relapses. The scarcity of genetic markers for P. vivax has hampered the analysis of important parasite phenotypes, such as patterns of relapse. In this context, the aim of this work was to study the variability of the parasites of primary infections and relapses from the same patients.
Materials and methods
Primary-Relapse paired samples of 30 patients were genotyped using 10 molecular markers (8 microsatellites and blocks 2 and 10 of MSP-1) by capillary electrophoresis on an automated DNA sequencer. Moreover, the presence of multiple infections was confirmed by cloning of amplicons and genotyping of different colonies (mean of 10 colonies per PCR product).
The majority of parasites showed distinct haplotypes in relapses compared to primary infection. It was demonstrated a high frequency of multiple-clone infections both in primary infection and relapse. A variation of predominant alleles among distinct markers in different malaria recidives of the same individual was observed. Therefore, haplotypes in relapse could also be identified in primary infections as a rare alleles.
Altogether our findings suggest that mechanisms involved in hypnozoites activation might not be based only on parasites genetic programming but also on host/enviroment factors.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.